17-46029955-CT-C

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The ENST00000262419.10(KANSL1):​c.*1520delA variant causes a splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.15 in 145,282 control chromosomes in the GnomAD database, including 2,095 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.15 ( 2095 hom., cov: 28)
Exomes 𝑓: 0.092 ( 0 hom. )

Consequence

KANSL1
ENST00000262419.10 splice_region

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.218

Publications

0 publications found
Variant links:
Genes affected
KANSL1 (HGNC:24565): (KAT8 regulatory NSL complex subunit 1) This gene encodes a nuclear protein that is a subunit of two protein complexes involved with histone acetylation, the MLL1 complex and the NSL1 complex. The encoded protein has been implicated in a variety of cellular processes including enhancer regulation, cell proliferation, and mitosis. Mutations in this gene are associated with Koolen-de Vries Syndrome. [provided by RefSeq, May 2022]
KANSL1 Gene-Disease associations (from GenCC):
  • Koolen-de Vries syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • Koolen-de Vries syndrome due to a point mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 17-46029955-CT-C is Benign according to our data. Variant chr17-46029955-CT-C is described in ClinVar as [Benign]. Clinvar id is 323732.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.22 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KANSL1NM_015443.4 linkc.*1520delA 3_prime_UTR_variant Exon 15 of 15 ENST00000432791.7 NP_056258.1 Q7Z3B3-1A0A024R9Y2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KANSL1ENST00000432791.7 linkc.*1520delA 3_prime_UTR_variant Exon 15 of 15 1 NM_015443.4 ENSP00000387393.3 Q7Z3B3-1

Frequencies

GnomAD3 genomes
AF:
0.150
AC:
21706
AN:
144930
Hom.:
2097
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.0446
Gnomad AMI
AF:
0.281
Gnomad AMR
AF:
0.183
Gnomad ASJ
AF:
0.245
Gnomad EAS
AF:
0.00301
Gnomad SAS
AF:
0.0772
Gnomad FIN
AF:
0.0762
Gnomad MID
AF:
0.220
Gnomad NFE
AF:
0.223
Gnomad OTH
AF:
0.187
GnomAD4 exome
AF:
0.0915
AC:
28
AN:
306
Hom.:
0
Cov.:
0
AF XY:
0.0824
AC XY:
15
AN XY:
182
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.0940
AC:
28
AN:
298
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
4
Other (OTH)
AF:
0.00
AC:
0
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.150
AC:
21697
AN:
144976
Hom.:
2095
Cov.:
28
AF XY:
0.141
AC XY:
9933
AN XY:
70504
show subpopulations
African (AFR)
AF:
0.0446
AC:
1766
AN:
39624
American (AMR)
AF:
0.183
AC:
2636
AN:
14428
Ashkenazi Jewish (ASJ)
AF:
0.245
AC:
833
AN:
3398
East Asian (EAS)
AF:
0.00322
AC:
16
AN:
4972
South Asian (SAS)
AF:
0.0775
AC:
352
AN:
4542
European-Finnish (FIN)
AF:
0.0762
AC:
675
AN:
8858
Middle Eastern (MID)
AF:
0.219
AC:
61
AN:
278
European-Non Finnish (NFE)
AF:
0.223
AC:
14738
AN:
65986
Other (OTH)
AF:
0.185
AC:
369
AN:
1996
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
799
1599
2398
3198
3997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0326
Hom.:
31
Bravo
AF:
0.148

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Syndromic intellectual disability Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MAPT-Related Spectrum Disorders Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.22
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs67801660; hg19: chr17-44107321; COSMIC: COSV52238148; COSMIC: COSV52238148; API